1-Hydroxybenzotriazole → 2-[2-(7-Ethoxy-5-{[6-(methylsulfonyl)pyridin-3-yl]oxy}-1H-indol-2-yl)-4,5-dihydro-1,3-thiazol-5-yl]-N-methylacetamide
Reaction equation
Cl.CN.[CH2:4]([O:6][C:7]1[CH:8]=[C:9]([O:25][C:26]2[CH:27]=[N:28][C:29]([S:32]([CH3:35])(=[O:34])=[O:33])=[CH:30][CH:31]=2)[CH:10]=[C:11]2[C:15]=1[NH:14][C:13]([C:16]1[S:17][CH:18]([CH2:21][C:22](O)=[O:23])[CH2:19][N:20]=1)=[CH:12]2)[CH3:5].O[N:37]1[C:41]2C=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C>CN(C)C=O.C(N(CC)CC)C>[CH2:4]([O:6][C:7]1[CH:8]=[C:9]([O:25][C:26]2[CH:27]=[N:28][C:29]([S:32]([CH3:35])(=[O:34])=[O:33])=[CH:30][CH:31]=2)[CH:10]=[C:11]2[C:15]=1[NH:14][C:13]([C:16]1[S:17][CH:18]([CH2:21][C:22]([NH:37][CH3:41])=[O:23])[CH2:19][N:20]=1)=[CH:12]2)[CH3:5]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To an ice-cooled and stirred mixture of methylamine hydrochloride (26 mg) and triethylamine (0.053 mL) in N,N-dimethylformamide (5 mL) were added [2-(7-ethoxy-5-{[6-(methylsulfonyl)pyridin-3-yl]oxy}-1H-indol-2-yl)-4,5-dihydro-1,3-thiazol-5-yl]acetic acid (90 mg), 1-hydroxybenzotriazole (52 mg) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (73 mg). After stirring at 4° C. to room temperature for 15 h, the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed successively with aqueous sodium hydrogen carbonate solution and brine, dried (MgSO4), filtered, and concentrated to give a pale yellow amorphous solid, which was crystallized from ethyl acetate-hexane to give the title compound (91 mg, 99%) as pale yellow crystals. MS 489 (MH+). mp 233-235° C.
Workup
- stirringAfter stirring at 4° C. to room temperature for 15 h
- customthe reaction mixture was partitioned between ethyl acetate and water
- washThe organic layer was washed successively with aqueous sodium hydrogen carbonate solution and brine
- dry with materialdried (MgSO4)
- filtrationfiltered
- concentrationconcentrated
- customto give a pale yellow amorphous solid, which
- customwas crystallized from ethyl acetate-hexane
Sources & evidence
- ORD record
- ord-f3f680b49ed14ffd9393aaafb44d184b
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08673942B2
Reaction notes
Loading…